Search - tctmd.com

Displaying 1 - 20 of 307

Sort: Relevancy | Date

News Daily News

GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

L.A. McKeown

February 06, 2026

News Daily News

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

Yael L. Maxwell

January 21, 2026

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

Caitlin E. Cox

December 10, 2025

News Daily News

Risk Calculators Miss Many Patients Who Present With First MI

Michael O'Riordan

November 21, 2025

News Conference News AHA 2025

Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids

Michael O'Riordan

November 10, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

Todd Neale

November 08, 2025

Presentation TCT 2025

TCT 1269: Associations Between AI Based-Quantitative Coronary Plaque Analysis, Calcium Score, and ASCVD Score with Major Adverse Cardiovascular Events: An Observational Study from Piedmont Heart Institute CCTA Registry

Presenter: Venkateshwar Polsani

October 28, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

Caitlin E. Cox

October 16, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Daily News

PREVENT Equations in BP Guidelines Means Better Treatment, the ACC/AHA Say

Yael L. Maxwell

August 28, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Conference News SCCT 2025

Cardiologists More Often Send Higher-Risk Patients for CAC Scans vs Generalists

Yael L. Maxwell

July 29, 2025

News Conference News SCCT 2025

AI-QCT Possibly Lessens Gap Between Ideal vs Actual Care for Patients at Risk of ASCVD

Yael L. Maxwell

July 22, 2025

Advertisement

GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

Year in Review: Top Prevention Stories of 2025

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

Risk Calculators Miss Many Patients Who Present With First MI

Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

TCT 1269: Associations Between AI Based-Quantitative Coronary Plaque Analysis, Calcium Score, and ASCVD Score with Major Adverse Cardiovascular Events: An Observational Study from Piedmont Heart Institute CCTA Registry

October 2025 Dispatch for the CV Team

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

PREVENT Equations in BP Guidelines Means Better Treatment, the ACC/AHA Say

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Cardiologists More Often Send Higher-Risk Patients for CAC Scans vs Generalists

AI-QCT Possibly Lessens Gap Between Ideal vs Actual Care for Patients at Risk of ASCVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content